Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (481-490 of 605) with videos related to

Pageof 61
Sort By:
Microbiology Spectrum|February 27, 2024
Evaluation of an automated feedback intervention to improve antibiotic prescribing among primary care physicians (OPEN Stewardship): a multinational controlled interrupted time-series studyJean-Paul R Soucy, Marcelo Low, Kamal R Acharya, et al.
Cancers|March 13, 2024
Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor GenomesHuma Q Rana, Diane R Koeller, McKenzie Walker, et al.
Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Breast Cancer Research and Treatment|November 10, 2016
Using machine learning to parse breast pathology reportsAdam Yala, Regina Barzilay, Laura Salama, et al.
Frontiers in Oncology|February 12, 2024
Development and evaluation of INT<sup>2</sup>GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndromeRaymond A Isidro, Anu Chittenden, McKenzie Walker, et al.
Cancer|June 14, 2017
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancerMark M Pomerantz, Sandor Spisák, Li Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
A phase Ib study of sapacitabine and olaparib in patients with BRCA1/2-mutated metastatic breast cancerFilipa Lynce, Noah Graham, Bose S Kochupurakkal, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2018
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancersN J Birkbak, Y Li, S Pathania, et al.
Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.
Pageof 61

Showing results (481-490 of 605) with videos related to

Sort By:
Pageof 61
Microbiology Spectrum|February 27, 2024
Evaluation of an automated feedback intervention to improve antibiotic prescribing among primary care physicians (OPEN Stewardship): a multinational controlled interrupted time-series studyJean-Paul R Soucy, Marcelo Low, Kamal R Acharya, et al.
Cancers|March 13, 2024
Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor GenomesHuma Q Rana, Diane R Koeller, McKenzie Walker, et al.
Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Breast Cancer Research and Treatment|November 10, 2016
Using machine learning to parse breast pathology reportsAdam Yala, Regina Barzilay, Laura Salama, et al.
Frontiers in Oncology|February 12, 2024
Development and evaluation of INT<sup>2</sup>GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndromeRaymond A Isidro, Anu Chittenden, McKenzie Walker, et al.
Cancer|June 14, 2017
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancerMark M Pomerantz, Sandor Spisák, Li Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
A phase Ib study of sapacitabine and olaparib in patients with BRCA1/2-mutated metastatic breast cancerFilipa Lynce, Noah Graham, Bose S Kochupurakkal, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2018
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancersN J Birkbak, Y Li, S Pathania, et al.
Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.
Pageof 61